NSNaiyuan Shao

Naiyuan Shao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Naiyuan Shao has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Xingliang Feng

    Affiliations Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China, Department of Urology, The First People’s Hospital of Changzhou, Changzhou, Jiangsu, China

    6 shared publications
  • Hongtao You

    Department of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China; Department of Neurosurgery, The First People's Hospital of Changzhou, Changzhou, Jiangsu, China

    4 shared publications
  • Bo Zhang

    Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, China

    3 shared publications
  • Chaojuan Huang

    Department of Rehabilitation Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China

    3 shared publications
  • Ligang Fan

    Department of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China

    3 shared publications
  • Wei Xia

    Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, China

    3 shared publications

Latest Publications

  • Open Access

    GNAI3 Promotes Aggressive Glioma Phenotypes and Is Associated with TGF-β-Related Mesenchymal Plasticity

    by Haoqian Wang, Qixiang Wang, Lin Chen, Qiliang Huang, Teng Cui, Li Wei, Ligang Fan, Naiyuan Shao, Peng Zhou

    Background/Objectives: Guanine nucleotide-binding protein G(i) subunit alpha 3 (GNAI3) participates in G-protein signaling and has been linked to glioma growth, but its contribution to invasive behavior and mesenchymal plasticity remains incompletely defined. This study examined the clinical relevance and functional effects of GNAI3 in glioma and evaluated its relationship with transforming growth factor-β (TGF-β)-associated mesenchymal changes. Methods:GNAI3 expression and clinical associations were analyzed using The Cancer Genome Atlas (TCGA)/Genotype-Tissue Expression (GTEx), Chinese Glioma Genome Atlas (CGGA), and Gene Expression Omnibus (GEO) datasets and were validated in five paired glioblastoma and peritumoral non-neoplastic tissues. Stable GNAI3 knockdown and overexpression models were established in U87-MG and U251-MG cells. Cell viability, migration, and invasion were evaluated using Cell Counting Kit-8 (CCK-8), Transwell, and wound-healing assays. Candidate GNAI3-associated proteins were screened by immunoprecipitation–mass spectrometry. The association between GNAI3 and TGF-β was examined by co-immunoprecipitation, and changes in protein abundance and phosphorylation of SMAD family members 2 and 3 (SMAD2/3) were assessed by Western blotting. The effect of GNAI3 depletion on tumor growth was evaluated in a U87-MG subcutaneous xenograft model. Results:GNAI3 expression was elevated in glioma and increased with World Health Organization (WHO) grade. Higher expression was associated with shorter overall survival in unadjusted analysis, whereas the association was attenuated after adjustment for clinical factors and molecular subtype. GNAI3 depletion reduced glioma-cell viability, migration, and invasion, whereas GNAI3 overexpression produced the opposite phenotype. GNAI3 expression correlated positively with cadherin 2 (CDH2) and vimentin (VIM), and these associations persisted after adjustment for histological grade. Co-immunoprecipitation showed co-enrichment of GNAI3 and TGF-β in protein complexes, and GNAI3 manipulation was accompanied by concordant changes in TGF-β, vimentin, N-cadherin, and zonula occludens-1 (ZO-1). In U251-MG cells, GNAI3 knockdown decreased the phosphorylated SMAD2 (p-SMAD2)/SMAD2/3 and phosphorylated SMAD3 (p-SMAD3)/SMAD2/3 ratios, whereas GNAI3 overexpression increased both ratios. In vivo, GNAI3 knockdown suppressed xenograft growth and reduced Ki67 and TGF-β expression. Conclusions: GNAI3 promotes aggressive glioma phenotypes in vitro and tumor growth in vivo. Its effects are accompanied by TGF-β-related mesenchymal changes, supporting further investigation of the molecular relationship between GNAI3 and TGF-β signaling without establishing pathway dependence from the present data.

  • Open Access

    Association of dietary live microbe intake with testosterone level in adult men: evidence from a national population-based study

    by Yiming Chen, Qianfeng Zhuang, Wei Xia, Naiyuan Shao, Bo Zhang, Xingliang Feng

    Testosterone deficiency (TD) is a prevalent disorder in men, associated with a range of health complications. Dietary live microbe intake has garnered attention for its potential to modulate gut microbiota and promote human health. This study aims to investigate the association between dietary live microbe intake and the risk of TD in a large, nationally representative sample. We analyzed data from the National Health and Nutrition Examination Survey (NHANES) for the years 2013–2016. Dietary live microbe intake was estimated using a 24-hour dietary recall, and participants were categorized into low, medium, and high intake groups. TD was defined as a serum testosterone level below 300 ng/dL. Multivariable weighted logistic regression models were used to assess the association between different dietary live microbe intake and TD risk, adjusting for potential confounders. A total of 4,034 male participants were included in the analysis. High dietary live microbe intake was associated with a significantly lower risk of TD in all models. In the fully adjusted model (Model 3), the odds ratio (OR) for TD in the high intake group was 0.71 (95% CI: 0.53 to 0.96; p = 0.03) compared to the low intake group. Subgroup analyses showed consistent results across different population characteristics, particularly among those without diabetes (OR: 0.64; 95% CI: 0.47 to 0.88; p = 0.01) and without cardiovascular disease (OR: 0.64; 95% CI: 0.47 to 0.88; p = 0.02). Restricted Cubic Spline analysis revealed a linear inverse relationship between food intake and TD risk in the medium and high intake groups. Our findings suggest that a higher intake of dietary live microbes is associated with a reduced risk of TD, highlighting the potential of dietary modifications as a preventive strategy for TD. Further research, including longitudinal studies and clinical trials, is necessary to confirm these results and explore the underlying mechanisms.


  • Open Access

    Association between uric acid/high-density lipoprotein cholesterol ratio and testosterone deficiency in adult American men: findings from the national health and nutrition examination survey 2011–2016

    by Wei Xia, Pinpeng Xie, Qianfeng Zhuang, Mingran Zhang, Naiyuan Shao, Yiming Chen, Xingliang Feng

    Testosterone deficiency (TD) is a globally recognized health concern, closely linked to disruptions in uric acid and lipid metabolism. Recently, the uric acid to high-density lipoprotein cholesterol ratio (UHR) has emerged as a comprehensive index for assessing the impact of inflammation and metabolic disturbances on disease risk. Therefore, we intended to explore the association of UHR with total testosterone levels and the risk of TD among US male adults. The analysis was based on data from the National Health and Nutrition Examination Survey (NHANES) conducted between January 2011 and December 2016. All eligible participants were males aged 20 and older who had complete data for UHR and testosterone levels. The associations between UHR and total testosterone levels and the risk of TD were examined using weighted multivariable linear and logistic regression analysis, respectively. To visually demonstrate the linear relationship between them, weighted regression using generalized additive models and smooth curve fits were applied. Furthermore, subgroup analyses with interaction tests were executed to evaluate the stability of the outcomes. Finally, a total of 2,844 men were enrolled in the study with the weighted mean age of 47.72 ± 0.42 years. Of these, 592 were diagnosed with TD. After controlling for potential confounders, the continuous UHR exhibited a positive linear correlation with the risk of TD (OR = 1.08, 95%CI: 1.04–1.11, P < 0.001) and a negative linear correlation with total testosterone levels (β=-7.82, 95%CI: -10.47 to -5.17, P < 0.0001). When UHR was categorized into quartiles, with Q1 as the reference, participants in Q4 had significantly lower total testosterone levels (β = -96.64, 95% CI: -129.39 to -63.90, P < 0.0001) and a higher risk of TD (OR = 2.35, 95%CI: 1.45–3.80, P = 0.001). These associations remained stable in subgroup analyses without significant interaction (all P for interaction > 0.05). The study indicates that, among adult males, higher UHR is negatively correlated with total testosterone levels and positively associated with the risk of TD. This suggests its potential value for early disease diagnosis and intervention. However, further clinical studies are needed to validate these findings.


  • Open Access

    Association between C-reactive protein-triglyceride glucose index and testosterone levels among adult men: analyses of NHANES 2015–2016 data

    by Bo Zhang, Yi Gu, Yiming Chen, Wei Xia, Naiyuan Shao, Qianfeng Zhuang, Xingliang Feng

    Background: The C-reactive protein-triglyceride glucose index (CTI) is a recently introduced index designed to simultaneously assess inflammation (via CRP) and insulin resistance (via the triglyceride-glucose index, TyG), both of which are recognized risk factors for declining testosterone levels in men. Aim: This study investigates the association between CTI and low testosterone levels in American adult men, aiming to evaluate CTI as a predictor of low testosterone level. Methods: Data from the 2015–2016 NHANES were used in this cross-sectional study, including men aged 20 and older. Multivariate linear and logistic regression models were employed to analyze the relationship between CTI, total testosterone levels, and the risk of low testosterone level. Receiver operating characteristic (ROC) curves were generated to assess the predictive performance of CTI for low testosterone level. Outcomes: The primary outcome was testosterone levels, with low testosterone level defined as a serum testosterone level below 300 ng/dL in adult men. Results: Among 878 participants, 189 had low testosterone level. The mean CTI was significantly higher in the low testosterone level group (9.39 ± 0.09) compared to the non- low testosterone level group (8.62 ± 0.05; P < .0001). After adjusting for covariates, higher CTI was significantly associated with lower total testosterone levels (β = –44.6, 95% CI: –66.34, –22.87, P < .001) and increased low testosterone level risk (OR = 1.84, 95% CI: 1.31, 2.57, P = .002). ROC analysis showed that CTI (AUC = 0.7357, 95% CI: 0.6975, 0.7739) outperformed TyG and VAI in predicting low testosterone level, highlighting its potential clinical value in assessing low testosterone status. Clinical Implications: Timely monitoring of testosterone levels in individuals with elevated CTI is clinically significant. Additionally, for those with TD, regular assessment of CTI may help in preventing future cardiovascular complications. Strengths and limitations: This study is the first to explore the relationship between CTI and low testosterone using a large sample from the NHANES database. However, due to the cross-sectional design, causal inference regarding CTI and low testosterone level cannot be drawn. Conclusions: CTI appears to be a more effective predictor of low testosterone level than TyG, CRP, or VAI, suggesting its usefulness as a simple, low-cost indicator for early TD risk assessment. Further research is needed to verify its clinical applicability across diverse populations.


  • Open Access

    Benefits of movement-based Behaviors on improving erectile function in American men: a nationwide survey study

    by Yiming Chen, Qianfeng Zhuang, Wei Xia, Naiyuan Shao, Bo Zhang, Xingliang Feng

    Background: Erectile dysfunction (ED) is a prevalent condition with significant psychological and physiological impacts. Recently, a new concept called movement-based behaviors (MBB) has been proposed, which includes four types of PA: vigorous PA (VPA), moderate-intensity PA (MPA), walking/cycling, and muscle-strengthening activities (MSA), and uses an MBB index (range 0–4) to estimate the combined effects of these activities on health outcomes. Aim: This study aims to evaluate the relationship between different types of physical activities (PA) and ED using the MBB index in a nationally representative sample of U.S. men. Methods: We analyzed data from the National Health and Nutrition Examination Survey (NHANES) 2001-2004, including 3435 male participants. Multivariate logistic regressions were performed to explore the associations, supplemented with subgroup analysis and sensitivity analysis. Outcomes: The assessment of PA in this study is based on four self-reported questions from the NHANES Mobile Examination Center interview, including VPA, MPA, walking/cycling, and MSA. The MBB index, ranging from 0 to 4, was used to assess combined PA types. ED was evaluated using a single-question self-assessment. Results: Higher MBB index values were associated with lower ED risk. Participants with an MBB index of 2 had a significantly lower risk of ED in Model 3 (OR = 0.65, 95% CI: 0.43-0.97, P = 0.04). Those with an MBB index of 3 or 4 had the lowest risk of ED across all models, with OR_Model1 = 0.29 (95% CI: 0.21-0.40, P < 0.0001), OR_Model2 = 0.52 (95% CI: 0.37-0.73, P < 0.001), and OR_Model3 = 0.61 (95% CI: 0.41-0.90, P = 0.02). However, this relationship was not significant in subgroups with severe ED or comorbid conditions. Clinical Implications: Our findings can provide clinicians with guidance to help patients personalize their selection of different exercise combinations. Strengths and Limitations: We explored the impact of different exercise combinations on reducing ED risk and innovatively proposed the MBB index for a comprehensive assessment of exercise benefits, supported by a large sample size and multivariable adjustments. However, the limitations of cross-sectional design and recall bias cannot be overlooked. Conclusion: The MBB index effectively demonstrates that combined PA can reduce ED risk, supporting tailored exercise recommendations for patients.

  • Top Cited Papers
    Open Access

    Association between the hemoglobin A1c/High-density lipoprotein cholesterol ratio and stroke incidence: a prospective nationwide cohort study in China

    by Chaojuan Huang, Hongtao You, Yuyang Zhang, Ligang Fan, Xingliang Feng, Naiyuan Shao

    Background: Stroke has emerged as an escalating public health challenge among middle-aged and older individuals in China, closely linked to glycolipid metabolic abnormalities. The Hemoglobin A1c/High-Density Lipoprotein Cholesterol (HbA1c/HDL-C) ratio, an integrated marker of glycolipid homeostasis, may serve as a novel predictor of stroke risk. Methods: Our investigation utilized data from the China Health and Retirement Longitudinal Study cohort (2011–2018). Stroke cases were identified based on self-reported, physician-confirmed diagnoses. Logistic regression models were established to determine the correlation between HbA1c/HDL-C and stroke prevalence (2011) as well as between cumulative mean HbA1c/HDL-C (2011–2015) and new stroke incidence (2015–2018). Additionally, smoothed curve fitting, subgroup analyses, and interaction tests were conducted to ensure the robustness of the findings. Results: In the cross-sectional analysis, 8,502 participants were enrolled, of whom 189 had a history of stroke. Our findings revealed a significant positive linear relationship between HbA1c/HDL-C and stroke prevalence after adjusting for covariates (OR: 1.26, 95% CI: 1.09–1.45). When HbA1c/HDL-C was categorized into tertiles, only the highest tertile (T3) showed a significant correlation with stroke prevalence compared to the lowest tertile (T1) (OR:1.71, 95% CI: 1.05–2.77). In the longitudinal analysis of 5,165 participants, 336 cases of new-onset stroke were identified over a follow-up period of 7 years. Adjusting for confounders, individuals with higher cumulative mean HbA1c/HDL-C exhibited an increased likelihood of new stroke incidence (OR: 1.14, 95% CI: 1.01–1.29). Using the T1 of cumulative mean HbA1c/HDL-C as a reference, the fully adjusted OR for stroke was 1.65 (95% CI: 1.21–2.24) in T2 and 1.54 (95% CI: 1.08–2.19) in T3. The predictive value of the HbA1c/HDL-C in stroke risk assessment have been significantly improved compared to the traditional HDL-C and HbA1c. Consistent associations were observed across most stratified subgroups. Conclusions: Elevated baseline and cumulative mean HbA1c/HDL-C levels are significantly associated with an increased risk of stroke among middle-aged and older individuals in China, underscoring the potential of HbA1c/HDL-C as a clinical marker for long-term stroke risk assessment and prevention strategies.


  • Top Cited Papers
    Open Access

    Association between C-reactive protein-triglyceride glucose index and depressive symptoms in American adults: results from the NHANES 2005 to 2010

    by Chaojuan Huang, Hongtao You, Yuyang Zhang, Zhiwei Li, Mingxu Li, Xingliang Feng, Naiyuan Shao

    The novel serum C-reactive protein-triglyceride glucose index (CTI) has been identified as an ideal parameter that integrates inflammation and insulin resistance, which are potential mechanisms underlying depressive symptoms. Our research aimed to investigate the association between CTI and depressive symptoms. Our cross-sectional investigation utilized data from the National Health and Nutrition Examination Survey conducted between 2005 and 2010. The integrated CTI was calculated as 0.412 × Ln (C-reactive protein) (mg/dL) + Ln [triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. The severity of depressive symptoms was evaluated through the continuous Patient Health Questionnaire-9 (PHQ-9) scores, and the categorical definition of depressive symptoms (PHQ-9 score ≥ 10) reflected moderate to severe symptoms. Survey-weighted linear and logistic regression models were conducted to establish the correlation between CTI and PHQ-9 scores, and between CTI and depressive symptoms. Moreover, subgroup analyses, interaction tests, and smoothed curve fitting were performed to scrutinize the steadiness of the results. A total of 5,954 participants were enrolled in our study, including 477 with depressive symptoms and 5,477 without. The results revealed a significant positive relationship between CTI and PHQ-9 scores (β: 0.40, 95% CI: 0.25,0.55, p < 0.001) and depressive symptoms (OR: 1.30, 95% CI: 1.06,1.61, p = 0.02). Additionally, individuals in the fourth quartile of CTI exhibited a higher likelihood of depressive symptoms than those in the first quartile (PHQ-9 score: β: 0.83, 95% CI: 0.39,1.26, p < 0.001; depressive symptoms: OR: 2.00, 95% CI:1.19,3.36, p = 0.01). Smooth curve fitting and subgroup analyses consistently demonstrated the positive relationship. Elevated CTI was correlated with a higher risk of depressive symptoms, underscoring CTI as a potential clinical indicator for identifying and stratifying depressive symptoms. Not applicable.


  • Open Access

    Association between a novel inflammation-lipid composite marker CRP/HDL and erectile dysfunction: evidence from a large national cross-sectional study

    by Yangyang Mei, Yiming Chen, Bo Zhang, Wei Xia, Naiyuan Shao, Xingliang Feng

    Background: Erectile dysfunction (ED) is one of the most common male sexual disorders, closely associated with both inflammation and lipid dysregulation. Recently, a novel inflammation-lipid composite marker, CRP/HDL, has been proposed to integrate the impact of both pathways on health, yet its relationship with ED remains unexplored. Therefore, our study aimed to investigate the potential association between the CRP/HDL ratio and ED.Methods: We utilized data from the NHANES database, known for its comprehensive and high-quality information. A total of 3,633 eligible participants from the 2001-2004 cycles were included. ED was assessed using a single-item questionnaire, while CRP and HDL were measured from blood samples. Multivariable regression analyses were performed to evaluate the association between CRP/HDL and ED after adjusting for potential confounders. Additionally, subgroup and sensitivity analyses were conducted to test the robustness of the results, and the linear trend between CRP/HDL and ED was visualized through smooth curve fitting.Results: Among the 3,633 participants, 1,027 had a history of ED. The CRP/HDL ratio was significantly higher in participants with ED compared to those without (10.53 ± 0.69 vs. 7.43 ± 0.35, P<0.001). In the regression analysis, a higher continuous CRP/HDL ratio was significantly associated with increased ED risk even after full adjustment (OR: 1.17, 95% CI: 1.05, 1.30; P = 0.01). Compared to Q1 of the CRP/HDL ratio, participants in Q2, Q3, and Q4 had progressively higher ED risks: Q2 (OR: 1.40, 95% CI: 1.01, 1.95; P = 0.05), Q3 (OR: 1.58, 95% CI: 1.10, 2.27; P = 0.02), and Q4 (OR: 1.85, 95% CI: 1.31, 2.60; P = 0.005), showing a clear linear trend. Subgroup analyses indicated consistent results across various populations with no significant interactions, and sensitivity analysis revealed that the CRP/HDL ratio also increased the risk of severe ED (OR: 1.14, 95% CI: 1.03, 1.26; P = 0.02).Conclusion: This is the first study to establish a significant positive association between an elevated CRP/HDL ratio and ED risk, suggesting its potential role in screening for ED risk and guiding timely interventions. However, further large-scale studies are needed to confirm our findings and explore the underlying mechanisms.


  • Open Access

    UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells

    by Ligang Fan, Hongtao You, Xiao Jiang, Yixuan Niu, Zhengxin Chen, Huibo Wang, Yuan Xu, Peng Zhou, Li Wei, Tianwei Jiang, et al.

    Background: The high degree of intratumoral genomic heterogeneity is a major obstacle for glioblastoma (GBM) tumors, one of the most lethal human malignancies, and is thought to influence conventional therapeutic outcomes negatively. The proneural-to-mesenchymal transition (PMT) of glioma stem cells (GSCs) confers resistance to radiation therapy in glioblastoma patients. POLD4 is associated with cancer progression, while the mechanisms underlying PMT and tumor radiation resistance have remained elusive. Method: Expression and prognosis of the POLD family were analyzed in TCGA, the Chinese Glioma Genome Atlas (CGGA) and GEO datasets. Tumorsphere formation and in vitro limiting dilution assay were performed to investigate the effect of UCHL3-POLD4 on GSC self-renewal. Apoptosis, TUNEL, cell cycle phase distribution, modification of the Single Cell Gel Electrophoresis (Comet), γ-H2AX immunofluorescence, and colony formation assays were conducted to evaluate the influence of UCHL3-POLD4 on GSC in ionizing radiation. Coimmunoprecipitation and GST pull-down assays were performed to identify POLD4 protein interactors. In vivo, intracranial xenograft mouse models were used to investigate the molecular effect of UCHL3, POLD4 or TCID on GCS. Result: We determined that POLD4 was considerably upregulated in MES-GSCs and was associated with a meagre prognosis. Ubiquitin carboxyl terminal hydrolase L3 (UCHL3), a DUB enzyme in the UCH protease family, is a bona fide deubiquitinase of POLD4 in GSCs. UCHL3 interacted with, depolyubiquitinated, and stabilized POLD4. Both in vitro and in vivo assays indicated that targeted depletion of the UCHL3-POLD4 axis reduced GSC self-renewal and tumorigenic capacity and resistance to IR treatment by impairing homologous recombination (HR) and nonhomologous end joining (NHEJ). Additionally, we proved that the UCHL3 inhibitor TCID induced POLD4 degradation and can significantly enhance the therapeutic effect of IR in a gsc-derived in situ xenograft model. Conclusion: These findings reveal a new signaling axis for GSC PMT regulation and highlight UCHL3-POLD4 as a potential therapeutic target in GBM. TCID, targeted for reducing the deubiquitinase activity of UCHL3, exhibited significant synergy against MES GSCs in combination with radiation.